Corcept Therapeutics Incorporated (CORT) Stock Forecast & Price Target
Price as of Nov 16, 2026 (intraday, delayed) · Analyst estimates retrieved Nov 10, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering Corcept Therapeutics Incorporated (CORT), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For Corcept Therapeutics Incorporated, analysts forecast revenue rising from $816.17M in 2025 to $3.09B in 2030; the average estimate for 2030 earnings per share is $11.93; with published estimates ranging from $10.66 to $13.69; 4 analysts contribute to these figures. These are forecasts published by analysts, not results.
Analyst price targets
A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
Corcept Therapeutics Incorporated (CORT) forecast — frequently asked questions
What is the analyst price target for Corcept Therapeutics Incorporated?
Analysts covering Corcept Therapeutics Incorporated (CORT) have a consensus price target of $132.80, 91.7% above the current price of $69.28. Published targets range from $50.00 to $165.00. A price target is a forecast, not a measure of value, and targets are revised often.
What are analysts forecasting for Corcept Therapeutics Incorporated's earnings?
The average analyst estimate for Corcept Therapeutics Incorporated (CORT) earnings per share in 2030 is 11.93, with individual estimates between 10.66 and 13.69.
How much revenue is Corcept Therapeutics Incorporated expected to make?
Analysts forecast Corcept Therapeutics Incorporated (CORT) revenue of $3.09B in 2030, based on 2 published estimates.
How many analysts cover CORT?
4 analysts contribute estimates for Corcept Therapeutics Incorporated (CORT). Thin coverage makes an average less reliable.
Analyst forecasts for other Medical - Pharmaceuticals stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.